Sign in:
 Email
 Password  save:
  
 Company Reports 
 
 
Membership is free, please Sign Up.
  
My Recent Searches
  Help
  
   
 
 
Get Insiders for : 
Ionis Pharmaceuticals Inc (IONS)  
$69.15 0.75 (1.1%) as of 4:30 Fri 10/3


Download
   
Exchange: Nasdaq National Market
Security Type: Common
Shares Out: 173,853,000
Market Cap: 12.02(B)
Last Volume: 998,037 Avg Vol: 990,381
52 Week Range: $25.51 - $68.4
Level I Sector: Health Care
Level II Sector: Drugs
Level III Sector: Drug Manufacturers - Other

Member Indexes:
    NASDAQ BIOTECHNOLOGY     NASDAQ COMPOSITE
    NASDAQ NNM COMPOSITE

Rankings:
     
Insider 3 Months    :   -
Insider 6 Months    : 9.8
Insider 3/6 Months : 10.4
Guru Rank Number :  162
Guru Rank Value     : 8.6
Guru Occurances    : 2

 

            6 Months   1 Year   2 Year  
 
Company Profile   Ionis Pharmaceuticals is engaged in RNA-targeted therapeuty. Co.'s commercial products are SPINRAZA, TEGSEDI and WAYLIVRA. SPINRAZA injection for intrathecal use is a survival motor neuron-2 directed antisense medicine indicated for the treatment of spinal muscular atrophy in pediatric and adult patients. TEGSEDI injection is an RNA-targeted medicine indicated for the treatment of polyneuropathy of hereditary transthyretin-mediated amyloidosis in adults. WAYLIVRA is an antisense medicine indicated as an adjunct to diet in adult patients with genetically confirmed FCS and at high risk for pancreatitis, in whom response to diet and triglyceride lowering therapy has been inadequate.

 
 
Summary  (Direct Transactions Only) 3 Months 6 Months 12 Months 24 Months
Total Shares Bought 0 15,000 20,000 20,000
Total Buy Value $0 $477,900 $658,979 $658,979
Total People Bought 0 1 1 1
Total Buy Transactions 0 1 2 2
Total Shares Sold 838,419 846,043 1,026,833 1,571,289
Total Sell Value $50,897,093 $51,113,474 $57,087,248 $84,178,172
Total People Sold 14 16 16 18
Total Sell Transactions 36 39 66 126
End Date 2025-07-06 2025-04-04 2024-10-04 2023-10-05

   
Records found: 1087
  Page 1 of 44  
Filer's Name Relation Title Off-Dir-10% Tran. Date Form Action Price Mkt Value D/I Shares Holdings
Rank

  
3m +/-  
Form
   Oneil Patrick R. EVP CLO & General Counsel   •       –      –    2025-10-02 4 AS $67.69 $4,377,054 D/D (64,664) 57,130 1%     
   Oneil Patrick R. EVP CLO & General Counsel   •       –      –    2025-10-02 4 OE $56.78 $3,813,257 D/D 64,664 91,591     -
   Swayze Eric EVP Research   •       –      –    2025-10-02 4 AS $66.23 $859,082 D/D (12,972) 37,302 1%     
   Swayze Eric EVP Research   •       –      –    2025-10-02 4 OE $53.77 $697,504 D/D 12,972 50,274     -
   Baroldi Joseph EVP, Chief Business Officer   •       –      –    2025-10-02 4 AS $68.01 $1,020,210 D/D (15,000) 31,926 1%     
   Baroldi Joseph EVP, Chief Business Officer   •       –      –    2025-10-02 4 OE $31.80 $477,000 D/D 15,000 46,926     -
   Wender Joseph H Director   –       •      –    2025-10-01 4 AS $65.50 $1,100,385 I/I (16,800) 92,035 5%     
   Swayze Eric EVP Research   •       –      –    2025-10-01 4 AS $66.09 $934,662 D/D (14,142) 37,302 5%     
   Swayze Eric EVP Research   •       –      –    2025-10-01 4 OE $53.77 $760,415 D/D 14,142 51,444     -
   Geary Richard S EVP, Chief Development Officer   •       –      –    2025-09-30 4 AS $65.24 $3,777,668 D/D (57,900) 79,657 6%     
   Geary Richard S EVP, Chief Development Officer   •       –      –    2025-09-30 4 OE $53.77 $3,113,283 D/D 57,900 137,557     -
   Hougen Elizabeth L EVP, Finance & CFO   •       –      –    2025-09-30 4 AS $65.26 $3,249,734 D/D (49,800) 110,500 6%     
   Hougen Elizabeth L EVP, Finance & CFO   •       –      –    2025-09-30 4 OE $53.77 $2,677,746 D/D 49,800 160,300     -
   Oneil Patrick R. EVP CLO & General Counsel   •       –      –    2025-09-30 4 AS $64.68 $958,976 D/D (14,827) 57,130 6%     
   Oneil Patrick R. EVP CLO & General Counsel   •       –      –    2025-09-30 4 OE $56.78 $841,877 D/D 14,827 71,957     -
   Oneil Patrick R. EVP CLO & General Counsel   •       –      –    2025-09-29 4 AS $64.54 $675,945 D/D (10,473) 57,130 8%     
   Oneil Patrick R. EVP CLO & General Counsel   •       –      –    2025-09-29 4 OE $56.78 $594,657 D/D 10,473 67,603     -
   Oneil Patrick R. EVP CLO & General Counsel   •       –      –    2025-09-12 4 AS $64.58 $109,787 D/D (1,700) 57,130 9%     
   Oneil Patrick R. EVP CLO & General Counsel   •       –      –    2025-09-12 4 OE $56.78 $96,526 D/D 1,700 58,830     -
   Baroldi Joseph EVP, Chief Business Officer   •       –      –    2025-09-09 4 AS $62.16 $742,838 D/D (11,950) 31,926 7%     
   Baroldi Joseph EVP, Chief Business Officer   •       –      –    2025-09-09 4 OE $31.80 $380,010 D/D 11,950 43,876     -
   Oneil Patrick R. EVP CLO & General Counsel   •       –      –    2025-09-09 4 AS $64.56 $1,355,661 D/D (21,000) 57,130 7%     
   Oneil Patrick R. EVP CLO & General Counsel   •       –      –    2025-09-09 4 OE $56.78 $1,274,580 D/D 21,000 58,130     -
   Bennett C Frank EVP, Chief Scientific Officer   •       –      –    2025-09-05 4 AS $59.60 $357,581 D/D (6,000) 82,679 13%     
   Baroldi Joseph EVP, Chief Business Officer   •       –      –    2025-09-05 4 AS $62.00 $15,500 D/D (250) 31,926 13%     
  1087 Records found
  1  2  3  4  5  6  7  8  9  Next   
  Page 1 of 44
  Transaction Code Key: Ownership Code Key
  B - Buy AB - Automatic Buy D - Direct Ownership
  S - Sell AS - Automatic Sell I - Indirect Ownership
  OE - Options Exercised A - Acquired
  IO - Initital Ownership D - Disposed
 
 
    Copyright © 2025 j3sg.com | Disclaimer & Terms of use          Products & Service  About Us  Contact Us